| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $73,661,405 ) (Continued on the next page) |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K23HL166771 | A Tailored mHealth Vaping Prevention Intervention for Adolescents with Congenital Heart Defects | 000 | 4 | NIH | 7/29/2026 | $174,420 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD107280 | Poly-Matching Causal Inference for Assessing Multiple Acute Medical Managements of Pediatric Traumatic Brain Injuries | 001 | 4 | NIH | 4/2/2026 | $54,851 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD107280 | Poly-Matching Causal Inference for Assessing Multiple Acute Medical Managements of Pediatric Traumatic Brain Injuries | 000 | 4 | NIH | 1/23/2026 | $493,665 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | RL1HD107783 | Collaborative Pediatric Critical Care Research Network - Clinical Site | 001 | 5 | NIH | 8/18/2026 | $153,999 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI175800 | Role of antibodies in hepatitis E virus infection | 000 | 4 | NIH | 4/7/2026 | $822,317 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | T32HL166149 | Integrative Research Training Program in Pediatric Cardiopulmonary Disease | 000 | 4 | NIH | 5/7/2026 | $359,952 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL165124 | The Role of Notch Signaling in Type 2 Diabetic Coronary Microvascular Disease | 000 | 4 | NIH | 3/10/2026 | $577,986 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL165124 | The Role of Notch Signaling in Type 2 Diabetic Coronary Microvascular Disease | 001 | 4 | NIH | 3/26/2026 | $18,251 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01NR020423 | Establishing Efficacy for the Congenital Heart Disease Physical Activity Lifestyle Intervention | 000 | 5 | NIH | 6/18/2026 | $572,943 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | P50MH127476 | The Center for Accelerating Suicide Prevention in Real-world Settings (ASPIRES) | 002 | 5 | NIH | 7/23/2026 | $2,485,119 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | T32CA269052 | Training Program in Basic and Translational Pediatric Oncology Research | 000 | 5 | NIH | 4/6/2026 | $363,018 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H4953004 | Healthy Start Initiative | 01 | 3 | HRSA | 5/20/2026 | $631,885 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H4953004 | Healthy Start Initiative | 00 | 3 | HRSA | 4/2/2026 | $140,658 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K23HL159312 | The Development and Evaluation of Visual Communication Tools to Convey Parental and Intergenerational Cardiovascular Disease Risk and Evoke Lifestyle Behavior Change | 000 | 5 | NIH | 6/26/2026 | $157,920 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD109000 | Targeted Investment and Meaningful Engagement to Improve MCH Outcomes: The TIME Study | 001 | 5 | NIH | 8/19/2026 | $0 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD109000 | Targeted Investment and Meaningful Engagement to Improve MCH Outcomes: The TIME Study | 001 | 5 | NIH | 8/19/2026 | $0 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD109000 | Targeted Investment and Meaningful Engagement to Improve MCH Outcomes: The TIME Study | 000 | 5 | NIH | 6/21/2026 | $100,000 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD109000 | Targeted Investment and Meaningful Engagement to Improve MCH Outcomes: The TIME Study | 000 | 5 | NIH | 6/21/2026 | $530,763 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H7624736 | Ryan White Part C Outpatient EIS Program | 02 | 15 | HRSA | 6/24/2026 | $0 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H7624736 | Ryan White Part C Outpatient EIS Program | 01 | 15 | HRSA | 5/11/2026 | $351,902 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H7624736 | Ryan White Part C Outpatient EIS Program | 00 | 15 | HRSA | 3/31/2026 | $75,556 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K08NS119878 | Reversal of Immunoparalysis Following Traumatic Brain Injury and Systemic Hemorrhage in a Juvenile Rat Model | 000 | 5 | NIH | 4/27/2026 | $187,635 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R03DK140423 | Defining Stat3 Antimicrobial Mechanisms in Human Urothelium | 000 | 2 | NIH | 5/12/2026 | $117,000 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL179812 | Novel pathogenesis of LVNC | 000 | 2 | NIH | 4/2/2026 | $669,388 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA248103 | Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects | 001 | 6 | NIH | 4/16/2026 | $54,436 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA248103 | Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects | 000 | 6 | NIH | 1/30/2026 | $489,921 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | UH3HL148693 | A Study Evaluating the Safety and Efficacy of Second-Generation Tissue Engineered Vascular Grafts (TEVG2) | 001 | 6 | NIH | 9/3/2026 | $974,238 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155282 | A human stem cell-based compartment-specific cardiac model for elucidating roles of NOTCH1 in congenital heart disease | 002 | 6 | NIH | 8/14/2026 | $789,007 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155282 | A human stem cell-based compartment-specific cardiac model for elucidating roles of NOTCH1 in congenital heart disease | 003 | 6 | NIH | 8/26/2026 | $0 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL148171 | Strategies to correct defective CF macrophage--mediated bacterial killing | 001 | 6 | NIH | 7/17/2026 | $761,274 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U24CA254445 | (EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank | 001 | 6 | NIH | 7/14/2026 | $2,110,316 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U01DK100866 | CUREGN 3.0 - Pediatric Nephrology Consortium - PCC | 000 | 14 | NIH | 7/24/2026 | $953,728 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R21MH136554 | Characterizing the role of sleep brain dynamics in the emergence of depression in adolescents | 000 | 2 | NIH | 4/28/2026 | $237,000 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R00HL161446 | Molecular Analysis of Airway Secretory Cells in Health and Disease | 000 | 4 | NIH | 3/6/2026 | $249,000 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DK115737 | The Contributions of Ribonuclease 4 & 7 to Urinary Tract Antibacterial Defense | 000 | 6 | NIH | 6/16/2026 | $685,156 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01NS085238 | Genetic modifiers of Duchenne Muscular Dystrophy | 000 | 10 | NIH | 7/30/2026 | $921,491 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K08CA290060 | A digital health parent coaching intervention to improve neurodevelopmental outcomes for young childhood cancer survivors in underserved communities | 000 | 2 | NIH | 2/27/2026 | $185,795 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL176685 | Role of cardiac m6A methyltransferases | 001 | 2 | NIH | 5/1/2026 | $22,329 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL176685 | Role of cardiac m6A methyltransferases | 000 | 2 | NIH | 3/20/2026 | $707,045 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01NS129784 | Deciphering brain mosaicism in drug-resistant epilepsy at cellular resolution | 001 | 4 | NIH | 2/28/2026 | $54,401 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01NS129784 | Deciphering brain mosaicism in drug-resistant epilepsy at cellular resolution | 000 | 4 | NIH | 1/31/2026 | $489,615 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | P50FD007961 | Midwest Pediatric Device Consortium (MPDC) | 000 | 4 | FDA | 8/27/2026 | $1,150,000 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI183877 | Animal Model to study heterogeneous outcomes of HCV Infection and Pathogenesis | 000 | 3 | NIH | 4/29/2026 | $780,961 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI190069 | Defining successful intrahepatic CD4+ T cell responses against the hepatitis C virus | 000 | 2 | NIH | 2/10/2026 | $525,277 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R03DK142029 | Identification of isoform-specific WT1 interaction partners | 000 | 3 | NIH | 12/15/2025 | $118,500 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01MH123746 | THE IMPACT OF PUBERTAL SUPPRESSION ON ADOLESCENT NEURAL AND MENTAL HEALTH TRAJECTORIES - Resubmission - 1 | 002 | 5 | NIH | 2/6/2026 | $728,119 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | T35DK129192 | Student Urinary Tract Program in Education and Research (SUPER) Summer Training Program | 000 | 5 | NIH | 8/11/2026 | $36,843 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 Children's Drive | Columbus | OH | 43205-2664 | FRANKLIN | USA | H4B15471 | Poison Control Stabilization and Enhancement Program | 00 | 18 | HRSA | 8/6/2026 | $430,001 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K23HL171862 | Myeloid-derived suppressor cells modulate disease severity in children with viral lower respiratory tract infections | 000 | 3 | NIH | 8/25/2026 | $180,199 |
|
